Navigation Links
Carnegie Mellon Researchers Develop Novel Tool to Rank Death Rates
Date:8/26/2009


Fischbeck and Gerard hope the new Web site will help bring focus to some of the discussion now raging over health care policy in the United States.

"It's much easier to make a persuasive argument when you have the facts to back it up, and this site provides all sides with the facts," Fischbeck said. "We believe that this tool, which allows anyone to assess their own risk of dying and to compare their risks with counterparts in the United States and Europe, could help inform the public and constructively engage them in the debate."

Carnegie Mellon funded the research, and the Web site development was coordinated through Carnegie Mellon's Center for the Study and Improvement of Regulation (CSIR), which is based in the Department of Engineering & Public Policy. CSIR research focuses on the use of science and risk information to support and evaluate regulatory decision-making. In cooperation with the Information Systems program, CSIR is developing a number of interactive tools in areas, such as traffic safety, mortality risk, vehicle technology and hospital admissions.

About Carnegie Mellon: Carnegie Mellon http://www.cmu.edu) is a private, internationally ranked research university with programs in areas ranging from science, technology and business, to public policy, the humanities and the fine arts. More than 11,000 students in the university's seven schools and colleges benefit from a small student-to-faculty ratio and an education characterized by its focus on creating and implementing solutions for real problems, interdisciplinary collaboration and innovation. A global university, Carnegie Mellon's main campus in the United States is in Pittsburgh, Pa. It has campuses in California's Silicon Valley and Qatar, and programs in Asia, Australia and Europe. The university is in the
'/>"/>

SOURCE Carnegie Mellon
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Carnegie Mellon Establishes Ray and Stephanie Lane Center for Computational Biology
2. Carnegie Mellon neuroscientist proposes new theory of brain flexibility
3. Carnegie Mellon algorithm identifies top 100 blogs for news
4. SuperArray Bioscience Corporation Licenses RNA Interference Patent From The Carnegie Institution
5. Carnegie Mellon study identifies where thoughts of familiar objects occur inside the human brain
6. NSF awards Carnegie Mellons Jacobo Bielak
7. Carnegie Mellon study shows just listening to cell phones significantly impairs drivers
8. ANSYS Sponsors Dinosaurs Exhibit at Carnegie Museum of Natural History
9. Carnegie Mellons Tepper School of Business to Host 2008 Cornerstones Symposium on Building City of the Future, March 25
10. Teams From Carnegie Mellon, Yale, Manitoba Win Tepper Schools 2008 McGinnis Venture Competition
11. Carnegie Mellon technique accelerates biological image analysis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...re/--JustintimefortheThanksgivingcelebration, tur...forcookingupadeliciousmeal:deep-friedturkeyin100%p... turkeyfrying.net alsoprovidesrecipesfromthele...takingtheturkeybeyondThanksgiving.Thenewlylaunched...ryingwith100%peanutoil. ,, "Ienjoyfryingwithpea...
(Date:11/23/2009)...s to treatment advances, study finds , ,...ontent of saliva changes as people age, and better... simple test to diagnose and treat age-related dis...ains numerous proteins that play a role in digesti...hers are trying to find ways to use these proteins...
(Date:11/23/2009)...Health System study has found that one out of five...ly 100 pounds or more overweight. , Researchers ...e 2 diabetes are obese, and 20.7 percent are morbi... 2 diabetes, 1 in 3 is morbidly obese. , "The ra... increasing at a very alarming rate, and this has ...
(Date:11/23/2009)...ave been a simple case for a New York auto acciden... charge. , New York (PRWE...e for New York auto accident attorneys passed to...rage turned fatal., , , , ,According to the New ...s shot and killed during a heated road-rage argume...
(Date:11/23/2009)...re/--ChristineHoehnehasjoined LocktonBenefitGroup ....HoehnewillserveasanAccountExecutiveinLockton,s In...neapolis office. ,, (Logo: http://www.newscom.c...ethrilledtohaveChristinejoinourteam,"saidPamEnrigh...hebroadensourabilitytoassistourmultinationalclient...
Breaking Medicine News(10 mins):Health News:Diabetics show alarming increase in morbid obesity 2Health News:An Incident of Road Rage Turns Into Murder 2Health News:Lockton Benefit Group Expands International Benefit Team 2
... that looks matter for everyone from presidential ...risis is forcing many consumers to re-evaluate the... and plastic surgeon polls are being release in co...tober 31st through November 5th. , "It appears mo...
...f Vertebral Compression Fracture Treatment Using...t, SAN JOSE, Calif., Oct. 28 DFine, Inc., a deve... vertebral compression fractures,(VCFs), has secur...ure Partners and Vanguard Ventures., DFine is ded...
...e Report Card Provides,Information on NY, NJ, RI, ...ty, Payments, LAKE SUCCESS, N.Y., Oct. 28 Health...U.S. have a unique tool for,evaluating the region,...ata on the cost and quality of care received by,me...
...f Universit Laval researchers has shown that the m...re exacerbated in the brains of mice fed a diet ri...the studywhich suggests that diets typical of most...e this, the team led by Frdric Calon used a type o...
...d 2008, HARRISBURG, Pa., Oct. 28 More than 600,P...al Conference of The,National Alliance on Mental I... "Today,s Family and the Faces of Mental Illness: ...open to the,public, will take place Wednesday, Oct...
...etween leading researchers in academia and industr...ds to discovery of method for promoting HEK 293 ce...rom colostrum. , Fort Col...ng the benefit of using recombinant lactoferrin (L...
Other Medicine News:Health News:Consumers and plastic surgeons say economy is cutting into cosmetic procedures 2Health News:DFine Secures $30 Million in Series D Funding 2Health News:Foundation Releases Comprehensive Regional Health Care Report Card 2Health News:Foundation Releases Comprehensive Regional Health Care Report Card 3Health News:Foundation Releases Comprehensive Regional Health Care Report Card 4Health News:A high-fat diet could promote the development of Alzheimer's 2Health News:NAMI Pennsylvania Announces Program for Annual Statewide Conference 2Health News:Global Scientific Research Collaboration Leads to Breakthrough in Culturing HEK 293 Cells in Animal-free Media 2
(Date:11/23/2009)...3/PRNewswire-FirstCall/-- LexiconPharmaceuticals,I...fromitsPhase2clinicalstudywith LX1031 inpatientswi...epresentedatGASTRO2009inLondonthisweek.Resultsfrom...mptoms,willbepresentedbyDr. PhilipM.Brown ,Lexicon...ber25,2009at2:30pmlocaltimeatthesessionentitled,"T...
(Date:11/23/2009)...RNewswire-FirstCall/--WoundManagementTechnologies,...rofspecialtymedicalproducts,announcedthatithasfile...ivemanagementbusinessupdatetoillustratethedevelopm...ncreased33.5%to$102,926vs.Q32008salesof$77,084. ,...27,892vs.Q32008shareholderequityof$(321,257) ,...
(Date:11/23/2009)...,Nov.23/PRNewswire-FirstCall/--Anesiva,Inc.(Nasdaq....U,PrichardhaveagreedtojointheAnesivaboardofdirect...esivaandArcionTherapeutics.Completionofthemergeris...previouslyannouncedAnesiva2009AnnualMeetingofStock...OysterPoint,Suite107A,SouthSanFrancisco,California...
Breaking Medicine Technology:Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3Building Healthier America Announces the High Five Program Addressing Factors Affecting the Energy Levels of Overweight Men 57152 1Building Healthier America Announces the High Five Program Addressing Factors Affecting the Energy Levels of Overweight Men 57152 2Building Healthier America Announces the High Five Program Addressing Factors Affecting the Energy Levels of Overweight Men 57152 3Texas Cardiac Arrhythmia Institute at St Davids Medical Center Orders 4 Odyssey Systems 57150 1Texas Cardiac Arrhythmia Institute at St Davids Medical Center Orders 4 Odyssey Systems 57150 2Texas Cardiac Arrhythmia Institute at St Davids Medical Center Orders 4 Odyssey Systems 57150 3Texas Cardiac Arrhythmia Institute at St Davids Medical Center Orders 4 Odyssey Systems 57150 4Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 1Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 2Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 3Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes 5004 4
...r Validate Lipidomic-Based Therapeutics as an Emer...ery, SAN DIEGO, Sept. 4 Lpath, Inc. (OTC Bulleti... agents against bioactive,lipids, reported positiv...,and AMD with Lpathomab(TM), the company,s mouse m...cid). These results confirm the expected potent,an...
...la., Sept. 4 In an extensive analysis of,clinical...rolimus-eluting,Coronary Stent was associated with...need for reintervention compared to the Taxus Sten... This meta-analysis of 16 randomized,clinical tria... kind to,date, is now posted on the Journal of the...
Other Medicine Technology:Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process 2Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process 3Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 2Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 3Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent 4
PROXIMATE ILS Circular Sizer Set
VALTRAC™ Reusable Purstring Device
EEA™ Reusable 34 mm Sizer
Calcitonin Assay Immunoradiometric (IRMA) Assay
Medicine Products: